Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Ageing as a risk factor for neurodegenerative disease

Research output: Contribution to journalReviewResearchpeer-review

  1. Calcitonin gene-related peptide - beyond migraine prophylaxis

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Does inflammation have a role in migraine?

    Research output: Contribution to journalReviewResearchpeer-review

  3. CGRP as the target of new migraine therapies - successful translation from bench to clinic

    Research output: Contribution to journalReviewResearchpeer-review

  4. The current role of MRI in differentiating multiple sclerosis from its imaging mimics

    Research output: Contribution to journalReviewResearchpeer-review

  5. Human models of migraine - short-term pain for long-term gain

    Research output: Contribution to journalReviewResearchpeer-review

  1. Automatically computed rating scales from MRI for patients with cognitive disorders

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ventriculoperitoneal Shunt Complications in the European Idiopathic Normal Pressure Hydrocephalus Multicenter Study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Ageing is the primary risk factor for most neurodegenerative diseases, including Alzheimer disease (AD) and Parkinson disease (PD). One in ten individuals aged ≥65 years has AD and its prevalence continues to increase with increasing age. Few or no effective treatments are available for ageing-related neurodegenerative diseases, which tend to progress in an irreversible manner and are associated with large socioeconomic and personal costs. This Review discusses the pathogenesis of AD, PD and other neurodegenerative diseases, and describes their associations with the nine biological hallmarks of ageing: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, mitochondrial dysfunction, cellular senescence, deregulated nutrient sensing, stem cell exhaustion and altered intercellular communication. The central biological mechanisms of ageing and their potential as targets of novel therapies for neurodegenerative diseases are also discussed, with potential therapies including NAD+ precursors, mitophagy inducers and inhibitors of cellular senescence.

Original languageEnglish
JournalNature reviews. Neurology
Volume15
Issue number10
Pages (from-to)565-581
Number of pages17
ISSN1759-4758
DOIs
Publication statusPublished - Oct 2019

ID: 58035588